# The role of meningioma integrated molecular profiling to improve patient management and disclose novel therapeutic targets

## TL;DR

This paper discusses how combining genetic and gene activity data can help better manage meningioma patients and discover new treatment options.

## Contribution

The novel approach integrates genome-wide association studies and transcriptomics to prioritize drug targets for meningioma.

## Key findings

- Combining genetic and gene expression data helps identify potential drug targets for meningioma.
- This integrated approach improves understanding of meningioma biology and informs patient management.

## Abstract

This scientific commentary refers to ‘Integrating genome-wide association studies and transcriptomics prioritizes drug targets for meningioma’, by Liao et al. (https://doi.org/10.1093/braincomms/fcaf053).